Robert Uhl | Westwicke ICR |
Joseph Turgeon | President & CEO |
Kurt Gustafson | CFO |
Francois Lebel | Chief Medical Officer |
Thomas Riga | COO |
Ed White | HC Wainwright |
Charles Zhu | Guggenheim Partners |
Sahil Kazmi | B. Riley FBR |
Good afternoon. My name is Rich and I will be your conference operator today. At this time, I would like to welcome everyone to the Spectrum Pharmaceuticals' First Quarter 2020 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.